| Robin S Weiner, MD | |
|
1310 W 22nd St, Sioux Falls, SD 57105-1501 | |
| (605) 328-8600 | |
| (605) 328-8601 |
| Full Name | Robin S Weiner |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 22 Years |
| Location | 1310 W 22nd St, Sioux Falls, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548216724 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 2003008581 (Missouri) | Secondary |
| 207NS0135X | Dermatology - Procedural Dermatology | 5902 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Usd Medical Center | Sioux falls, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center | 8325950215 | 707 |
News Archive
Following incidents of deaths of high school athletes who collapse suddenly during practice or a game, new guidelines for screening prep athletes for hidden heart problems before the start of a season had been in place since 1996. About one of every 30,000 to 50,000 high school athletes dies each year from cardiac arrest.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target date for its priority review of the Biologics License Application (BLA) for BENLYSTA® (belimumab) as a potential treatment for systemic lupus erythematosus (SLE) from December 9, 2010 to March 10, 2011.
Scientists at the University of East Anglia (UEA) have discovered a rogue gene which - if blocked by the right drugs - could stop cancer in its tracks.
A new study has uncovered a link between being overweight or obese in adolescence and an increased risk of developing colon cancer in adulthood. Obesity was also associated with an elevated risk of developing rectal cancer.
› Verified 6 days ago
| Entity Name | Sanford Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396764254 PECOS PAC ID: 0244143824 Enrollment ID: O20031110000532 |
News Archive
Following incidents of deaths of high school athletes who collapse suddenly during practice or a game, new guidelines for screening prep athletes for hidden heart problems before the start of a season had been in place since 1996. About one of every 30,000 to 50,000 high school athletes dies each year from cardiac arrest.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target date for its priority review of the Biologics License Application (BLA) for BENLYSTA® (belimumab) as a potential treatment for systemic lupus erythematosus (SLE) from December 9, 2010 to March 10, 2011.
Scientists at the University of East Anglia (UEA) have discovered a rogue gene which - if blocked by the right drugs - could stop cancer in its tracks.
A new study has uncovered a link between being overweight or obese in adolescence and an increased risk of developing colon cancer in adulthood. Obesity was also associated with an elevated risk of developing rectal cancer.
› Verified 6 days ago
| Entity Name | Sanford Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821017880 PECOS PAC ID: 8325950215 Enrollment ID: O20040115000388 |
News Archive
Following incidents of deaths of high school athletes who collapse suddenly during practice or a game, new guidelines for screening prep athletes for hidden heart problems before the start of a season had been in place since 1996. About one of every 30,000 to 50,000 high school athletes dies each year from cardiac arrest.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target date for its priority review of the Biologics License Application (BLA) for BENLYSTA® (belimumab) as a potential treatment for systemic lupus erythematosus (SLE) from December 9, 2010 to March 10, 2011.
Scientists at the University of East Anglia (UEA) have discovered a rogue gene which - if blocked by the right drugs - could stop cancer in its tracks.
A new study has uncovered a link between being overweight or obese in adolescence and an increased risk of developing colon cancer in adulthood. Obesity was also associated with an elevated risk of developing rectal cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robin S Weiner, MD 1310 W 22nd St, Sioux Falls, SD 57105-1501 Ph: (605) 328-8600 | Robin S Weiner, MD 1310 W 22nd St, Sioux Falls, SD 57105-1501 Ph: (605) 328-8600 |
News Archive
Following incidents of deaths of high school athletes who collapse suddenly during practice or a game, new guidelines for screening prep athletes for hidden heart problems before the start of a season had been in place since 1996. About one of every 30,000 to 50,000 high school athletes dies each year from cardiac arrest.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target date for its priority review of the Biologics License Application (BLA) for BENLYSTA® (belimumab) as a potential treatment for systemic lupus erythematosus (SLE) from December 9, 2010 to March 10, 2011.
Scientists at the University of East Anglia (UEA) have discovered a rogue gene which - if blocked by the right drugs - could stop cancer in its tracks.
A new study has uncovered a link between being overweight or obese in adolescence and an increased risk of developing colon cancer in adulthood. Obesity was also associated with an elevated risk of developing rectal cancer.
› Verified 6 days ago
Dr. Jocelyn June Frohm, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1310 W 22nd St, Sioux Falls, SD 57105 Phone: 605-328-8600 Fax: 605-328-8601 | |
Lainee Goettsche, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6701 S Minnesota Ave, Sioux Falls, SD 57108 Phone: 605-322-6960 Fax: 605-322-6961 | |
Anna Brook Bahnson, MD Dermatology Medicare: Medicare Enrolled Practice Location: 6701 S Minnesota Ave, Sioux Falls, SD 57108 Phone: 605-322-6960 Fax: 605-322-6961 | |
Rachel Samuelson, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1400 W 22nd St, Sioux Falls, SD 57105 Phone: 605-357-1380 | |
Sarah Christine Kerr, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1310 W 22nd St, Sioux Falls, SD 57105 Phone: 605-328-8600 | |
Jana B Johnson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6701 S Minnesota Ave, Sioux Falls, SD 57108 Phone: 605-322-6960 Fax: 605-322-6961 | |
Dr. Marcus Lee Frohm, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1310 W 22nd St, Sioux Falls, SD 57105 Phone: 605-328-8600 Fax: 605-328-8601 |